Antonio Regalado - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Antonio Regalado

Antonio Regalado

Creator
0 followers

Biomedicine editor at MIT Technology Review; covers cutting-edge biotech breakthroughs and their societal impact.

Recent Posts

Nominate Under‑35 Biotech Trailblazers for 2026 Award
Social•Jan 9, 2026

Nominate Under‑35 Biotech Trailblazers for 2026 Award

Do you know an up and coming someone killing it in biotech? If they're under 35 years of age, please nominate them for the 2026 Technology Review 35 Innovators Under 35 Award. (or just email me. address is in bio) https://t.co/90fwj4GjNU

By Antonio Regalado
FDA's Prasad Paradox: Conflicting Strictness on Bespoke Therapies
Social•Jan 8, 2026

FDA's Prasad Paradox: Conflicting Strictness on Bespoke Therapies

Predictions for cell therapy and gene therapy in 2026. Most interesting is the "Prasad Paradox", meaning a general state of contradiction at the FDA biologics division around laxness and strictness, including misapplication of the concept of "bespoke" therapies.

By Antonio Regalado